Back to Authors

Powderly, John

0000-0002-7608-0380

A5048575626 | I4210093858

Mayo Clinic

Carolina BioOncology Institute

Citations 2

636 A phase 1, open-label, dose escalation and expansion study of CUE-102 monotherapy in HLA-A*0201 positive patients with WT1-positive recurrent/metastatic cancers

Regular and Young Investigator Award Abstracts | November 7, 2022 | Volume: No volume available | Issue: No issue available | Pages: A667-A667

10.1136/jitc-2022-sitc2022.0636

717 Interim clinical update of the phase 1b trial of ATRC-101 as monotherapy or in combination with pembrolizumab for select advanced solid tumors

Regular and Young Investigator Award Abstracts | November 7, 2022 | Volume: No volume available | Issue: No issue available | Pages: A750-A750

10.1136/jitc-2022-sitc2022.0717